✦ LIBER ✦

P643 Anemia in patients with inflammatory bowel disease – A nationwide cross-sectional study

✍ Scribed by Portela, F.; Cotter, J.; Vasconcelos, H.; Ministro, P.; Caldeira, P.; Morna, H.; Sousa, H.; Peixe, P.; Duarte, A.; Cremers, I.; Deus, J.; Cravo, M.; Lago, P.; Lopes, S.; Gonçalves, R.; Belo, A.; Magro, F.

Book ID: 122202912
Publisher: Oxford University Press
Year: 2014
Tongue: English
Weight: 145 KB
Volume: 8
Category: Article
ISSN: 1873-9946
DOI: 10.1016/S1873-9946(14)60763-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prevalence and Pathogenesis of Anemia in

Prevalence and Pathogenesis of Anemia in Inflammatory Bowel Disease: A Cross Sectional Study in a Large Tertiary Center

✍ Tanwar, Sudeep ;Lipman, Gideon ;Parkes, Julie ;McCartney, Sara 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 187 KB

Anemia in patients with chronic inflamma

Anemia in patients with chronic inflammatory bowel disease

✍ Cornelius C Cronin; Fergus Shanahan 📂 Article 📅 2001 🏛 Nature Publishing Group 🌐 English ⚖ 37 KB

Sa1193 Daytime Dysfunction in Patients W

Sa1193 Daytime Dysfunction in Patients With Inflammatory Bowel Disease Associated With Mucosal Inflammation: A Cross Sectional Study

✍ Ali, Tauseef; Zhao, Daniel; Crosby, Amber; Orr, William C.; Madhoun, Mohammad F. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 474 KB

P601 Prevalence of anemia in Serbian pat

P601 Prevalence of anemia in Serbian patients with inflammatory bowel disease

✍ Mijac, D.; Jankovic, G.; Krstic, M.; Culafic, D.; Rankovic, I.; Tomic, D.; Djura 📂 Article 📅 2014 🏛 Oxford University Press 🌐 English ⚖ 51 KB

Anemia Management in Patients With Infla

Anemia Management in Patients With Inflammatory Bowel Disease: A Multicenter Non-Interventional Study

✍ Blumenstein, Irina ;Dignass, Axel U. ;Vollmer, Stefan ;Mangal-Weber, Susanne ;Ha 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 39 KB

Risk of malignant lymphoma in patients w

Risk of malignant lymphoma in patients with inflammatory bowel diseases: A Dutch nationwide study

✍ A.C.W. Vos; N. Bakkal; R.C. Minnee; M.K. Casparie; D.J. de Jong; G. Dijkstra; P. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 319 KB 👁 2 views

Background: Immune suppressant medications such as thiopurines and anti-tumor necrosis factor agents are important for maintaining disease control in most patients with inflammatory bowel diseases (IBDs); however, their use has been associated with the development of malignant lymphoma. The purpose